⌘K

Login Start Free

Home/Filings/4/0001628280-21-012225

4//SEC Filing

JACOB GARY S 4

Accession 0001628280-21-012225

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 10:06 AM ET

Size

20.1 KB

Accession

0001628280-21-012225

Insider Transaction Report

Form 4

Period: 2021-06-10

Cardiff Oncology, Inc.CRDF

Director

Transactions

Other
Stock Options
2021-06-10+223→ 76,106 total
Exercise: $372.96From: 2017-01-04Exp: 2023-06-10→ Common Stock (223 underlying)
Other
Stock Options
2021-06-10+755→ 76,106 total
Exercise: $21.60From: 2019-01-23Exp: 2023-06-10→ Common Stock (755 underlying)
Other
Stock Options
2021-06-10+44,734→ 76,106 total
Exercise: $2.48From: 2020-06-20Exp: 2023-06-10→ Common Stock (44,734 underlying)
Other
Stock Options
2021-06-10+28,858→ 76,106 total
Exercise: $2.60From: 2021-06-10Exp: 2023-06-10→ Common Stock (28,858 underlying)
Other
Stock Options
2021-06-10+293→ 76,106 total
Exercise: $447.84Exp: 2023-06-10→ Common Stock (293 underlying)
Other
Stock Options
2021-06-10+218→ 76,106 total
Exercise: $316.08From: 2014-12-11Exp: 2023-06-10→ Common Stock (218 underlying)
Other
Stock Options
2021-06-10+223→ 76,106 total
Exercise: $516.96From: 2016-03-17Exp: 2023-06-10→ Common Stock (223 underlying)
Other
Stock Options
2021-06-10+530→ 76,106 total
Exercise: $51.84From: 2018-10-04Exp: 2023-06-10→ Common Stock (530 underlying)

Footnotes (3)

[F1]In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 28,858 stock options to June 10, 2021 from June 17, 2021. In addition, the Compensation Committee extended the expiration date of the stock options to June 10, 2023.
[F2]Expiration date of the stock options was extended to June 10, 2023.
[F3]8,805 of the stock options vest immediately. 4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017.

Documents

1 file

4
wf-form4_162376598346799.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001266802

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 10:06 AM ET
Size: 20.1 KB

View on SEC.gov